ETHYL 3-(2-(TRIFLUOROMETHYL)PHENYL)BUTANOATE, 95.0%, 1g

Cyclohexane-1,2,3,4,5,6-hexaone octahydrate, 95.0%, 1g

5,5'-(Methylenebis(azanediyl))bis(1,3,4-thiadiazole-2(3H)-thione), 95%, 1g

4-((1S,2S,5R)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclohexyl)morpholine 4-oxide, 98%, 5g

2-Propoxy-4H-pyrido[1,2-a]pyrimidin-4-one, 97.0%, 1mg

2-Bromo-4-(tert-butoxy)-4-oxobutanoic acid, 95%, 5g

6-Fluoro-3-iodo-1H-indazole, 95.0%, 25g

Methyl 5-bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylate, 97%, 1g

4-Chloro-1,5-dimethyl-1 H -pyrazole-3-carboxylic acid, 95.0%, 1g

Mercury(I) chloride, min. 99.5%, pa, ACS, 50 g, glass packaging

N-(Piperidin-4-yl)-3-(trifluoromethyl)benzamide hydrochloride, 1g

(2-Bromoethyl)phosphonic Acid>98.0%(T)200mg

4-(Tert-butyl)-3-fluoroaniline, 98%, 25g